This event will demonstrate how unique and transferable technical expertise in viral vector development can significantly accelerate the development path and future-proof gene therapy products.
This webinar, titled 'Viral Vector Manufacturing Success Stories: Onboarding to GMP Production', will feature a presentation by:
Attendees will learn about: Cutting-edge, end-to-end automation of analytical assays
Design of Experiments to optimize vector production
Considerations for product comparability during process changes
Case studies to demonstrate enhancements to viral vector production and successful process transfer to GMP operations
The webinar will be held at
About
One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors.
Contact:
Tel: +44 (0)7519 109325
Email: partnering@oxb.com
Sophia Bolhassan
Tel: +44 (0) 7394 562 425
Email: ir@oxb.com
(C) 2024 Electronic News Publishing, source